|
MYD88 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74378306133849E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.56380497229725E-11 |
| Normal-vs-Stage2 |
5.554100E-04 |
| Normal-vs-Stage3 |
8.77670047749746E-10 |
| Normal-vs-Stage4 |
5.78159999875538E-08 |
| Stage1-vs-Stage2 |
4.315200E-01 |
| Stage1-vs-Stage3 |
7.024800E-01 |
| Stage1-vs-Stage4 |
3.807000E-01 |
| Stage2-vs-Stage3 |
3.301400E-01 |
| Stage2-vs-Stage4 |
2.377200E-01 |
| Stage3-vs-Stage4 |
6.215800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20046203480706E-12 |
| Normal-vs-AfricanAmerican |
1.369510E-02 |
| Normal-vs-Asian |
1.399970E-02 |
| Caucasian-vs-AfricanAmerican |
1.448180E-02 |
| Caucasian-vs-Asian |
1.182960E-01 |
| AfricanAmerican-vs-Asian |
2.917900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58300056291228E-11 |
| Normal-vs-Female |
1.0362044555734E-11 |
| Male-vs-Female |
5.023800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.278200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.03720040836686E-10 |
| Normal-vs-Age(61-80Yrs) |
3.25872662187976E-12 |
| Normal-vs-Age(81-100Yrs) |
1.369790E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.052800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.107400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.511400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.145600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.164200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.820000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.644000E-03 |
| Normal-vs-Grade 2 |
4.07419653569718E-11 |
| Normal-vs-Grade 3 |
5.75960390492014E-11 |
| Normal-vs-Grade 4 |
2.78230000039237E-07 |
| Grade 1-vs-Grade 2 |
6.942200E-01 |
| Grade 1-vs-Grade 3 |
4.841800E-01 |
| Grade 1-vs-Grade 4 |
2.279000E-01 |
| Grade 2-vs-Grade 3 |
7.602200E-01 |
| Grade 2-vs-Grade 4 |
2.886000E-01 |
| Grade 3-vs-Grade 4 |
3.876600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.0238255515892E-12 |
| Normal-vs-ccB subtype |
2.00490002377762E-09 |
| ccA subtype-vs-ccB subtype |
6.771600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79359860297268E-11 |
| Normal-vs-N1 |
1.404360E-02 |
| N0-vs-N1 |
3.140400E-01 |
|
|
